DEC 16, 2019 11:33 AM PST

Vaccine To Protect Against The Zika Virus

WRITTEN BY: Nouran Amin

Scientists at The University of Texas Medical Branch at Galveston present for the first time how a single high dose vaccine can protect a pregnant mouse along with its fetus from the effects of the Zika virus. These findings confirm that single dose of the vaccine is mild in potency and not enough to provide protection against the Zika infection—and thus, a higher does provides a greater efficacy while maintaining safety.

Learn more about the Zika virus:

“Preventing birth defects in developing fetuses is an important goal of the Zika virus vaccine but studies on vaccinations in pregnant females have been lacking, raising a number of important questions that are critical to the clinical development and regulatory approval of Zika vaccines,” said UTMB’s Pei-Yong Shi, senior author and the I.H. Kempner professor at the department of biochemistry and molecular biology.

Results were published in the journal Nature Communications.

“Could vaccination during pregnancy protect against infection and transmission to the fetus? Does pregnancy affect immune responses to Zika vaccination? Does maternal immunity from vaccination during pregnancy protect newborns against infection?” adds Shi which his laboratory are currently working on improving the efficacy of the vaccine.

Researchers also learned from there studies that a high-dose or more immunogenic vaccine is necessary during pregnancy since a growing a fetus weakens the mothers immune system. They also learned that a live-attenuated vaccine is safe in pregnant female mice and their fetuses. For example, no side-effects were observed on pregnancy, fetal development or infant behavior. Overall, the study suggests that their vaccine may be a great protective agent not only for pregnant women but for non-pregnant people as well.

Source: The University of Texas Medical Branch

About the Author
BS/MS
Nouran is a scientist, educator, and life-long learner with a passion for making science more communicable. When not busy in the lab isolating blood macrophages, she enjoys writing on various STEM topics.
You May Also Like
APR 25, 2022
Microbiology
How a Serious Infection Can Cause Mood Disorders
APR 25, 2022
How a Serious Infection Can Cause Mood Disorders
When a pathogen invades the body, the immune system has to mount a response, which involves inflammation. But inflammati ...
MAY 19, 2022
Drug Discovery & Development
Vaccine for Deadly Mosquito-borne Virus Shows Promising Trial Results
MAY 19, 2022
Vaccine for Deadly Mosquito-borne Virus Shows Promising Trial Results
Eastern equine encephalitis virus (EEEV), Western equine encephalitis (WEEV), Venezuelan equine encephalitis (VEEV) are ...
MAY 19, 2022
Drug Discovery & Development
Repurposed Antibiotic Shows Promise Against COVID-19 in Mice
MAY 19, 2022
Repurposed Antibiotic Shows Promise Against COVID-19 in Mice
An antibiotic known as clofoctol has shown promise in treating SARS-CoV-2 in mice. The corresponding study was published ...
MAY 23, 2022
Drug Discovery & Development
A Possible Therapy for Infantile Spasms
MAY 23, 2022
A Possible Therapy for Infantile Spasms
Researchers at Texas Children’s Hospital have identified a possible cause of infantile spasms (IS) as well as a po ...
JUN 13, 2022
Microbiology
Mucus Contains Fungus-Fighting Molecules
JUN 13, 2022
Mucus Contains Fungus-Fighting Molecules
The human body plays host to a variety of microorganisms, including fungi like Candida albicans. Some strains of Candida ...
JUN 20, 2022
Health & Medicine
In a Small Study, Experimental Immunotherapy Drug for Rectal Cancer has a High Success Rate
JUN 20, 2022
In a Small Study, Experimental Immunotherapy Drug for Rectal Cancer has a High Success Rate
The New England Journal of Medicine published results from a small study by researchers at New York’s Memorial Slo ...
Loading Comments...